THIS IS AN ARCHIVED (2022) VERSION OF NANOCANADACONFERENCE.CA
RETURN TO THE MAIN SITE.
CMC Microsystems
Hurry, get your tickets today!
Details Here

Philina Lee

Chief Commercial Officer

Blueprint Medicines

Philina brings more than 15 years of biopharmaceutical industry leadership experience, with a strong track record in product commercialization, portfolio strategy, and successfully building high growth organizations while fostering a strong company culture. She currently serves as Chief Commercial Officer of Blueprint Medicines. Since joining the company in August 2014, she has been instrumental in building the company's portfolio from research-stage onwards, laying the groundwork for the commercial strategy that is driving the successful launches of AYVAKIT® (avapritinib) and GAVRETO® (pralsetinib). Philina also serves on the board of Fusion Pharmaceuticals. She earned a B.S. in Biochemistry from the University of Alberta, and a Ph.D. in Cell Biology from the Massachusetts Institute of Technology.

Philina Lee's LinkedIn
blueprintmedicines.com

Sessions Philina Lee is a part of

Wednesday, June 8, 2022

Realizing the promise of precision medicine

10:00 am to 10:30 am
in Hall D

Talk Description

© 2022 NanoCanada. All rights reserved.

THIS IS AN ARCHIVED (2022) VERSION OF NANOCANADACONFERENCE.CA
RETURN TO THE MAIN SITE.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram